S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
Log in
(Ad)
In my 40+ year career, I have yet to see a convergence of three significant factors that has me this optimistic about the stock market. I believe 2020 could deliver the largest wealth-building opportunity in a generation. Don't miss out on this historic year.

ETR:INH - Indus Stock Price, Forecast & News

€39.05
-0.35 (-0.89 %)
(As of 01/21/2020 04:00 PM ET)
Add
Compare
Today's Range
€38.75
Now: €39.05▼
€39.20
50-Day Range
€37.95
MA: €39.22▼
€40.85
52-Week Range
€31.30
Now: €39.05▼
€47.60
Volume8,457 shs
Average Volume22,718 shs
Market Capitalization$954.79 million
P/E Ratio17.52
Dividend Yield3.79%
BetaN/A
INDUS Holding AG is a private equity firm specializing in mergers and acquisitions and corporate spin-offs. The firm does not invest in retail and service companies, pure trading or consumer goods businesses, companies with significant dependencies on individual business partners, start-ups, turnarounds, mature businesses, and companies undergoing restructuring. Read More…

Industry, Sector and Symbol

Stock Exchange ETR
Industry Conglomerates
Sub-IndustryN/A
SectorIndustrials
Current SymbolETR:INH
Previous Symbol
CUSIPN/A
CIKN/A
Webhttp://www.indus.de/
Phone+49-2204-40000

Debt

Debt-to-Equity Ratio98.56
Current Ratio1.84
Quick Ratio0.82

Price-To-Earnings

Trailing P/E Ratio17.52
Forward P/E Ratio10.36
P/E Growth2.49

Sales & Book Value

Annual Sales$1.77 billion
Price / Sales0.54
Cash Flow€5.17 per share
Price / Cash Flow7.56
Book Value€29.12 per share
Price / Book1.34

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees10,679
Outstanding Shares24,450,500
Market Cap$954.79 million
Next Earnings Date2/20/2020 (Estimated)
OptionableNot Optionable

Receive INH News and Ratings via Email

Sign-up to receive the latest news and ratings for INH and its competitors with MarketBeat's FREE daily newsletter.

INH Rates by TradingView

(Ad)

If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

Indus (ETR:INH) Frequently Asked Questions

What is Indus' stock symbol?

Indus trades on the ETR under the ticker symbol "INH."

When is Indus' next earnings date?

Indus is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for Indus.

What price target have analysts set for INH?

3 equities research analysts have issued 1 year price targets for Indus' stock. Their forecasts range from €40.00 to €51.00. On average, they anticipate Indus' stock price to reach €47.00 in the next twelve months. This suggests a possible upside of 20.4% from the stock's current price. View Analyst Price Targets for Indus.

What is the consensus analysts' recommendation for Indus?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indus in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Indus.

Has Indus been receiving favorable news coverage?

Media coverage about INH stock has trended somewhat positive on Tuesday, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Indus earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Indus.

Who are some of Indus' key competitors?

What other stocks do shareholders of Indus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Indus investors own include NetSol Technologies (NTWK), Hexcel (HXL), Masco (MAS), Watkin Jones (WJG), Wizz Air (WIZZ), Total Produce (TOT), St. James's Place (STJ), NMC Health (NMC), Mondi (MNDI) and DCC (DCC).

Who are Indus' key executives?

Indus' management team includes the folowing people:
  • Dr. Johannes Schmidt, Chairman of the Management Board (Age 58)
  • Mr. Rudolf Weichert, Member of Management Board (Age 56)
  • Mr. Axel Meyer, Member of Management Board (Age 51)
  • Dr. Jörn Großmann, Member of Management Board (Age 51)
  • Ms. Julia Pschribülla, Investor Relations Mang.

What is Indus' stock price today?

One share of INH stock can currently be purchased for approximately €39.05.

How big of a company is Indus?

Indus has a market capitalization of $954.79 million and generates $1.77 billion in revenue each year. Indus employs 10,679 workers across the globe.View Additional Information About Indus.

What is Indus' official website?

The official website for Indus is http://www.indus.de/.

How can I contact Indus?

Indus' mailing address is Koelner Strasse 32, BERGISCH GLADBACH, 51429, Germany. The company can be reached via phone at +49-2204-40000.


MarketBeat Community Rating for Indus (ETR INH)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  151 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  271
MarketBeat's community ratings are surveys of what our community members think about Indus and other stocks. Vote "Outperform" if you believe INH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Featured Article: How to build a Fibonacci channel
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel